Eurepa MF (Repaglinide/ Metformin) 2/500mg – 100 tablet

USD $103.87

Each Eurepa MF contains Rpaglinide and Metformin with 100 tablets. It is used to lower blood sugar in patients with high blood sugar (diabetes).

ATC Classification: A10BD14
Active Ingrediant: Repaglinide/Metformin
Generic Name: Eurepa MF
Manufacturer: Torrent
Strength: 2/500mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 TABLET

Important update for customers in the USA:

Most of the World has stopped all packages mailing to the USA due to De Minimus Exemption.

  1. The only or best option right now is trans shipment to the USA, we are holding India post and express mail shipments until India sets up a taxation / tariff collection system on our side which they say can take 1 month or longer.
  2. We ship normally to the UK, AUS, Japan, and most others. The situation only involves the USA.
  3. For people who have placed an order for express mail we will ship this out once India mail is open or you can contact us to make arrangements to ship through Trans Shipping and pay the tariff and shipping costs this way.
  4. We are very sorry for this, the USA policy shift came fast, without rules or regulations, and not understanding of what other countries should do.
  5. As things develop we will adjust our shipping prices and operations to best service you.
Thanks for your patience.
Examples of Packages sent

What is this drug used for?

It is used to lower blood sugar in patients with high blood sugar (diabetes).

 

Pronunciation

(re PAG li nide & met FOR min)

 

Medication Safety Issues

Sound-alike/look-alike issues:

PrandiMet may be confused with Avandamet, Prandin

 

Storage/Stability

Do not store above 25?C (77?F). Protect from moisture.

 

Adverse Reactions

The following information reflects the frequency of adverse effects experienced by patients who received the repaglinide/metformin fixed-dose combination product. Also see individual agents.

>10%:

Central nervous system: Headache (22%)

Endocrine & metabolic: Hypoglycemia (33%)

Gastrointestinal: Diarrhea (19%), nausea (15%)

Respiratory: Upper respiratory tract infection (11%)